Pictilisib (GDC-0941)

Catalog No.S1065

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

Price Stock Quantity  
USD 240 In stock
USD 120 In stock
USD 170 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Pictilisib (GDC-0941) Chemical Structure

Pictilisib (GDC-0941) Chemical Structure
Molecular Weight: 513.64

Validation & Quality Control

Cited by 57 publications:

7 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Pictilisib (GDC-0941) is available in the following compound libraries:

PI3K Inhibitors with Unique Features

  • Pan PI3K Inhibitor

    LY294002 Pan-PI3Kα/δ/β inhibitor, IC50=0.5 μM/0.57 μM/0.97 μM.

  • Most Potent PI3K Inhibitor

    Duvelisib (IPI-145, INK1197) PI3K δ, IC50=1 nM.

  • FDA-approved PI3K Inhibitor

    CAL-101 (Idelalisib, GS-1101) Approved by FDA for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma.

  • Newest PI3K Inhibitor

    GSK2636771 Potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.

Product Information

  • Compare PI3K
    Compare PI3K Products
  • Research Area
  • Inhibition Profile
  • Pictilisib (GDC-0941) Mechanism
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.
Targets p110α [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)
p110β [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)

 View  More

IC50 3 nM 3 nM 33 nM 75 nM
In vitro GDC-0941 is equipotent against PI3Kα and PI3Kδ as well as PI3Kα mutants E545-K and H1047-R, displaying modest levels of selectivity against PI3Kβ (10-fold) and PI3Kγ (25-fold), and greater levels of selectivity against members of PI3K class II, III, and IV, including C2β, Vps34, DNA-PK, and mTOR. GDC-0941 potently inhibits the phosphorylation of Akt in U87MG, PC3, and MDA-MB-361 cells with IC50 of 46 nM, 37 nM, and 28 nM, respectively. GDC-0941 inhibits the proliferation of U87MG, A2780, PC3, and MDA-MB-361 cells with IC50 of 0.95 μM, 0.14 μM, 0.28 μM, and 0.72 μM, respectively. [1] GDC-0941 treatment potently inhibits the proliferation of both trastuzumab-sensitive and -insensitive HER2-amplified cells with IC50 of 149-944 nM. GDC-0941 inhibits proliferation of HER2-amplified cells that harbor PIK3CA mutations with IC50 of <500 nM, and effectively inhibits both proliferation and viability of HER2-amplified breast cancer cells that are resistant to trastuzumab due to PTEN loss. [2] GDC-0941 significantly inhibits the growth of HCT116, DLD1 and HT29 cells with GI50 of 1081 nM, 1070 nM and 157 nM, respectively. [3] GDC-0941 inhibits tumor cell proliferation, induces apoptosis and suppresses centroblast population. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
Sf9NWfCc3NZU2mwYYPlJGF{e2G7MWWxJIg>M{HVc2ROW09?NVnOcGJOUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDQTVNMKHBzMUDk[Yx1[SCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJINw\XiycnXzd4lv\yCyOEXhcJBp[SC5aYToJGlEPTBib3[gNE4xODNizszNNIXISmEyQDd3NE[1OC=>
Sf9Mn7kT4lv[XOnIFHzd4F6M1jSWlEhcA>?MVjEUXNQM2rLS2lvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiUFmzT{BxOTFyYnX0ZUBJOTB2Nz3SJI12fGGwdDDlfJBz\XO|ZXSgbY4hW2Z7IHPlcIx{KGOxZYjwdoV{e2mwZzDwPFVidHCqYTD3bZRpKEmFNUCgc4YhOC5yMEOg{txOMoHCNVg4PTR4NUS=
Sf9Mm\yT4lv[XOnIFHzd4F6M3HUN|EhcA>?NXy4VFExTE2VTx?=NVniN2s1UW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDQTVNMKHBzMUDi[ZRiKEV3NEWtT{BufXSjboSg[ZhxemW|c3XkJIlvKFOoOTDj[YxteyClb3X4dJJme3OrbnegdFg2[WyyaHGge4l1cCCLQ{WwJI9nKDBwMECzJO69VQ>?MXGxPFc2PDZ3NB?=
Sf9NGXSUHJMcW6jc3WgRZN{[Xl?MXyxJIg>NUPHZ3JnTE2VTx?=M1HZW2lvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiUFmzT{BxOTFyYnX0ZUBmgHC{ZYPz[YQhcW5iU3[5JINmdGy|IHPv[ZhxemW|c3nu[{BxQDWjbIDoZUB4cXSqIFnDOVAhd2ZiMD6wN|Mh|ryPNFL1R4MyQDd3NE[1OC=>
Sf9MljXT4lv[XOnIFHzd4F6M{HuVVEhcA>?NETBbFZFVVORMoLiTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCSSUPLJJAyOTCjbIDoZUBmgHC{ZYPz[YQhcW5iU3[5JINmdGy|IHPv[ZhxemW|c3nu[{BxQDWjbIDoZS=>NFL0R5EyQDd3NE[1OC=>
MDA-MB-361NFzVPI1HfW6ldHnvckBCe3OjeR?=NVLZNJdCOiCqNEX5[nRFVVORM1\uNWlvcGmkaYTpc44hd2ZiQXv0JHNmejR5MzDwbI9{eGixconsZZRqd25iaX6gbJVu[W5iTVTBMW1DNTN4MTDj[YxteyC5aYToJHBKUzOFQTDFOVQ2NUtibYX0ZZRqd25id3n0bEBKSzVyIH;mJFAvODJ6IN88US=>M{P0cFE5PzV2NkW0
PC3NGP2TJJHfW6ldHnvckBCe3OjeR?=MXGyJIg>M1LmRWROW09?MYTJcohq[mm2aX;uJI9nKEGtdDDT[ZI1PzNicHjvd5Bpd3K7bHH0bY9vKGmwIGDUSW4udnWubDDoeY1idiCSQ{OgZ4VtdHNid3n0bEBKSzVyIH;mJFAvODN5IN88US=>NWD4SmNEOTh5NUS2OVQ>
U87MGM3zRbmZ2dmO2aX;uJGF{e2G7NWPwSZpnOiCqNVrqcZU{TE2VTx?=MUTJcohq[mm2aX;uJI9nKEGtdDDT[ZI1PzNicHjvd5Bpd3K7bHH0bY9vKGmwIGDUSW4udnWubDDoeY1idiCXOEfNS{Bk\WyuczD3bZRpKEmFNUCgc4YhOC5yNE[g{txOMkLpNVg4PTR4NUS=
MDA-MB-361M{HpRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2XXfFk3KGh?MlTOSG1UVw>?M3O2OWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVTBMW1DNTN4MTDj[YxteyC5aYToJHBKUzOFQTDFOVQ2NUtibYX0ZZRqd25id3n0bEBKSzVyIH;mJFAvPzJizszNNH;lSJMyQDd3NE[1OC=>
A2780MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\XbVk3KGh?Ml3GSG1UVw>?Mlj3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDMke4NEBk\WyuczD3bZRpKFCLS{PDRUBidmRiUGTFUkBufXSjdHnvckB4cXSqIFnDOVAhd2ZiMD6xOEDPxE1?NH2zeZAyQDd3NE[1OC=>
PC3NW\0WXdrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDmNnQ6PiCqM3PHbmROW09?MkD1TWM2OD1yLkK4JO69VQ>?MXixPFc2PDZ3NB?=
U87MGMn31S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF;Ucoo6PiCqNV3iepVpTE2VTx?=NGPzem5KSzVyPUCuPVUh|ryPMmj6NVg4PTR4NUS=
Sf9MXHLbY5ie2ViQYPzZZk>MmSxN|AhdWmwM1LDUGROW09?M2H0S2lvcGmkaYTpc44hd2ZiaIXtZY4hWEl|S3fhcY1iKGW6cILld5Nm\CCjc4Pld5Nm\CCjczDhcY92dnRib3[gRXRRKGOxboP1cYVlKHerdHigTWM2OCCxZjCwMlA1OiEQvF2=NVW2NYI5OjJ3NEizOFI>
RAW 264.7NGO3VVZMcW6jc3WgRZN{[Xl?NUPFS3FmQTBibXnuM2KzPGROW09?NFjjTmhKdmirYnn0bY9vKG:oIHj1cYFvKFCLM1vnZY1u[SCneIDy[ZN{\WRiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCDS2SgdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjJ7ODFOwG0>NVTPTJk5OjJ3NEizOFI>
Sf9M3fHPGtqdmG|ZTDBd5NigQ>?NFnmdmgyKGh?NIjjWI1KdmirYnn0bY9vKG:oIFfTWE1nfXOnZDDoeY1idiC{ZXPvcYJqdmGwdDDQTVNM[mW2YTDlfJBz\XO|ZXSgbY4h[mGldXzveolzfXNiaX7m[YN1\WRiU1[5JINmdGy|IIfpeIghUUN3MDDv[kAxNjBzNzFOwG0>NYrsNVViOjN3NEC2OFU>
Sf9MV3LbY5ie2ViQYPzZZk>NGS1PHgyKGh?NInwVYVKdmirYnn0bY9vKG:oIFfTWE1nfXOnZDDoeY1idiC{ZXPvcYJqdmGwdDDQTVNM\GWudHGg[ZhxemW|c3XkM4\mWFI{PTRyNkS1
Sf9NUO1WnB7U2mwYYPlJGF{e2G7NX65cXRrOSCqNHvienNKdmirYnn0bY9vKG:oIFfTWE1nfXOnZDDoeY1idiC{ZXPvcYJqdmGwdDDQTVNM\2GvbXGg[ZhxemW|c3XkMUSyN|U1ODZ2NR?=
Sf9MoXqT4lv[XOnIFHzd4F6NWrlZm1ZOSCqNVnNZ4hnUW6qaXLpeIlwdiCxZjDHV3Qu\nW|ZXSgbJVu[W5icnXjc41jcW6jboSgVGk{U2GucHjhJIV5eHKnc4Pl[C=>M{HYUFI{PTRyNkS1
SKOV3NYj2O|l{U2mwYYPlJGF{e2G7MV2xJO69VQ>?NXTDbZVWOSCqMme4SG1UVw>?MUDJcohq[mm2aX;uJI9nKFCLM1vhcJBp[SCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEGtdDDT[ZI1PzNicHjvd5Bpd3K7bHH0bY9vM1rKR|I{OzZyM{S4
MCF7NX;sV2hJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWKxJO69VQ>?MWi5OkBpNGexV2lFVVORMXzHTVUxRTBwMEewNkDPxE1?NFPwb3ozOzN4MEO0PC=>
SKOV3M2XQcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHLOXWkyKM7:TR?=NYXFeVBQQTZiaB?=M3PV[2ROW09?NFPFU2tIUTVyPUCuNVQ4PiEQvF2=NVfQdWNwOjN|NkCzOFg>
PC3MmTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUC2TGJSPzJiaB?=MkXMSG1UVw>?NYixSHFHUUN3ME2wMlI5KM7:TR?=NYOzepBTOjF7OEG3NVQ>
MCF7.1NWrNTGtZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVS3NkBpMlOxSG1UVw>?NFnNU|lCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlcvOSClZXzsd{BmgHC{ZYPzbY5oKEiHUkKg[4Vv\SC5aYToJGlEPTBib3[gNE4zQCEQvF2=MV[yNVk5OTdzNB?=
MCF7-neo/Her2MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrObZc4OiCqMoeySG1UVw>?MWLJR|UxRTBwMkmg{txONW[xfoN[OjN4NkK5NFM>
MCF7-neo/Her2M1TxZWtqdmG|ZTDBd5NigQ>?MlfTTY5pcWKrdHnvckBw\iCSSUPLZYxxcGFiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKEGNVDDwbI9{eGixconsZZRqd25iYYSgV|Q4OyC5aYToJGlEPTBib3[gNE4xODdizszNNIHnUIYzOzZ4MkmwNy=>
PC3MnqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLFWZI4OiCqMWfEUXNQM2LBZmVEPTB;MD6zOEDPxE1?MmXENlE6QDV4M{m=
MCF7.1M4LGUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX:3NkBpNX\meFJiTE2VTx?=MV\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkeuNUBk\WyuczDlfJBz\XO|aX7nJHBKO0ujbIDoZUBufXSjboSge4l1cCCHQ{WwJI9nKDBwM{mg{txONETiOVkzOTl6NU[zPS=>
PC3NUXTTnZyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LKdFczKGh?MWHEUXNQNVPrZmdSSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDQR|Mh[2WubIOg[IVncWOrZX70JIlvKFCWRV6ge4l1cCCLQ{WwJI9nKDBwM{mg{txOMWSyNFA2ODZ4OR?=
MCF7.1M1jOfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHSOnU{PzJiaB?=MX7EUXNQMl60RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3MlEh[2WubIOg[ZhxemW|c3nu[{BRUTONYXzwbIEhdXW2YX70JJdqfGhiSVO1NEBw\iByLkO0JO69VQ>?MkT5NlAxPTB4Nkm=
MCF7.1NHq3PJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LGblczKGh?MkDwSWM2OD1yLkeyJO69VQ>?NW\KZ|BbOjB|NE[2OVY>
NCI-H1975MWnDfZRwfG:6aXOgRZN{[Xl?MYi3NkBpMUXJR|UxRTBwMkeg{txOMl\jNlMxPTl3NEW=
H460MWDDfZRwfG:6aXOgRZN{[Xl?MVW3NkBpNH:3UYVKSzVyPUCuPFch|ryPMWWyN|A2QTV2NR?=
HT-29MVrDfZRwfG:6aXOgRZN{[Xl?NGTab484OiCqMW\JR|UxRTBwNk[g{txOMlyzNlMxPTl3NEW=
HepG2MmnLR5l1d3SxeHnjJGF{e2G7NF[3NIg4OiCqMUDJR|UxRTFizszNNEKxbHUzOzB3OUW0OS=>
SGC7901NEi4WIJEgXSxdH;4bYMhSXO|YYm=MmGwO|IhcA>?NFXWOZhKSzVyPUGuPEDPxE1?M{G0elI{ODV7NUS1
NCI-H226NVjpW4NbS3m2b4TvfIlkKEG|c3H5MmDWO|IhcA>?NFHjeIdKSzVyPUKuPUDPxE1?MXyyN|A2QTV2NR?=
A549NFjoXI1EgXSxdH;4bYMhSXO|YYm=MXq3NkBpM2TuNGlEPTB;Nj65JO69VQ>?MWKyN|A2QTV2NR?=
U87MGMWnDfZRwfG:6aXOgRZN{[Xl?NYLoOJlYPzJiaB?=NH;tPWFKSzVyPUeuO|ch|ryPMUSyN|A2QTV2NR?=
HBC4MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFLqW5Rtd2eJSUWwQU03NjB|IF2=Mn7YNlI{OzZ{NE[=
BSY1MoXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7sc4dIUTVyPT22MlkxKE1?Mn\uNlI{OzZ{NE[=
HBC5MmjqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvsc4dIUTVyPT22MlYxKE1?NH7mXW0zOjN|NkK0Oi=>
MCF7M2L5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDoTIZ{dG:pR1m1NF0uPy5|MzDNNGTGOXUzOjN|NkK0Oi=>
MDA-MB-231MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYLJW2k{dG:pR1m1NF0uPS52NjDNM4jZOFIzOzN4MkS2
U251M4fIZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3KcI9oT0l3ME2tOU42OCCPMlPoNlI{OzZ{NE[=
SF268MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{LOPIxw\0eLNUC9MVUvOzliTR?=NIG5TmIzOjN|NkK0Oi=>
SF295M2PtRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXsc4dIUTVyPT22MlM4KE1?M2DhPVIzOzN4MkS2
SF539NGHaS4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnKwcI9oT0l3ME2tOk42OCCPNYrtb4tHOjJ|M{[yOFY>
SNB75NX7ZdJJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1jpSIxw\0eLNUC9MVcvOTBiTR?=MVuyNlM{PjJ2Nh?=
SNB78NXHvbXU3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHhOndtd2eJSUWwQU03NjV{IF2=M{TEVFIzOzN4MkS2
HCC2998NILvTI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrsc4dIUTVyPT22MlI6KE1?MVmyNlM{PjJ2Nh?=
KM12MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfWd2JRdG:pR1m1NF0uPS55NjDNNYDvSZZUOjJ|M{[yOFY>
HT-29M4TZ[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHKRmZtd2eJSUWwQU03NjNyIF2=NHezN3QzOjN|NkK0Oi=>
HCT15NEXSU2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXsc4dIUTVyPT22MlEzKE1?NGfJUXkzOjN|NkK0Oi=>
HCT116Mn:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3;UdYxw\0eLNUC9MVUvQDdiTR?=NHjPPJQzOjN|NkK0Oi=>
NCI-H23MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYHsc4dIUTVyPT21Mlc{KE1?M{XSc|IzOzN4MkS2
NCI-H226NW\MWHhsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MljOcI9oT0l3ME2tOk4zOSCPM1HKXlIzOzN4MkS2
NCI-H522MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfsc4dIUTVyPT22MlU5KE1?M16xN|IzOzN4MkS2
NCI-H483NWL4NZcxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXfQdnRLdG:pR1m1NF0uPi53NjDNNHq0bo0zOjN|NkK0Oi=>
A549NHnpUYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrsc4dIUTVyPT22MlE2KE1?M2TwS|IzOzN4MkS2
DMS273MkfrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PyW4xw\0eLNUC9MVYvPDNiTR?=NWTYUIxwOjJ|M{[yOFY>
DMS114NV;YNnJXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYqweIxNdG:pR1m1NF0uPS57MjDNNI\FWlYzOjN|NkK0Oi=>
LOXIMVINEni[3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGnqb5htd2eJSUWwQU03NjJ7IF2=NELPSm8zOjN|NkK0Oi=>
OVCAR3MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{TN[oxw\0eLNUC9MVYvPzFiTR?=NETpOZIzOjN|NkK0Oi=>
OVCAR4MkHWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\CcGltd2eJSUWwQU02Njd4IF2=NUH2N2hwOjJ|M{[yOFY>
OVCAR5NEnZUGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33Kcoxw\0eLNUC9MVYvOjZiTR?=Mmn1NlI{OzZ{NE[=
OVCAR8M4Ds[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYXsc4dIUTVyPT21Mlc{KE1?NITCPYszOjN|NkK0Oi=>
SKOV3M2roc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGCwRnVtd2eJSUWwQU03NjV{IF2=M{\tW|IzOzN4MkS2
RXF631LMnzrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7ncI9oT0l3ME2tOk45QCCPMmTXNlI{OzZ{NE[=
ACHNMnzsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XKSIxw\0eLNUC9MVYvODdiTR?=NYPYT4J3OjJ|M{[yOFY>
St-4M2DXdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fWZ4xw\0eLNUC9MVUvPTZiTR?=NXXIeINYOjJ|M{[yOFY>
MKN1MmTWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDjeHg3dG:pR1m1NF0uPy5yODDNMUeyNlM{PjJ2Nh?=
MKN7NWHPe3l{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\XcI9oT0l3ME2tOk42OCCPMVOyNlM{PjJ2Nh?=
MKN28MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXTmblk5dG:pR1m1NF0uPS53MjDNMkXxNlI{OzZ{NE[=
MKN45MnzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NULVRYhkdG:pR1m1NF0uPi53NTDNNITQdlYzOjN|NkK0Oi=>
MKN74M{HFUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoGycI9oT0l3ME2tOk4xOiCPNVfZVpZ[OjJ|M{[yOFY>
DU145MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7YUZFtd2eJSUWwQU02Njh3IF2=NI\5SmQzOjN|NkK0Oi=>
PC3NWm2RpllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfsc4dIUTVyPT22MlY3KE1?NYTLTGI1OjJ|M{[yOFY>
ES5NHvBTnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlzzTWM2OD13MD6yNUBvVQ>?M{HSeXNCVkeHUh?=
HHNXL2SmRVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4fSb2lEPTB;MUGxMlA5KG6PNG\ydZpUSU6JRWK=
MHH-PREB-1NGW4SZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTFzND6zJI5OMYDTRW5ITVJ?
NCI-H1770NFjzUIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mo\NTWM2OD1zMkOuPFYhdk1?NV\KVZVmW0GQR1XS
HuO9MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV7JR|UxRTJyNj6wNkBvVQ>?MkX6V2FPT0WU
HAL-01M2LtWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnmTWM2OD1{ME[uO|Mhdk1?M2Lte3NCVkeHUh?=
NOS-1NGrN[VdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXjTWM2OD1{MUGuPFIhdk1?NGTEXZVUSU6JRWK=
HGC-27Mmm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mk\tTWM2OD1{MUKuOVchdk1?MoezV2FPT0WU
NB69MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTJ2NT6yO{BvVQ>?M4fvN3NCVkeHUh?=
RS4-11MoDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPCTWM2OD1{NkGuO|Yhdk1?NGq2TnFUSU6JRWK=
DOKMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{LUUWlEPTB;M{CxMlchdk1?NHu0OVdUSU6JRWK=
LB2241-RCCMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTNyMz64OEBvVQ>?M2rHNXNCVkeHUh?=
NCI-H1623NIPIb2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlTqTWM2OD1|MESuNFghdk1?M1jUXXNCVkeHUh?=
YH-13MoXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmXLTWM2OD1|MESuN|Ihdk1?NFy4WJhUSU6JRWK=
BPH-1NUfCUoF{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTNzNDDuUS=>MkLCV2FPT0WU
AN3-CANHvRe5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWrIfoRtUUN3ME2zOFAvOzdibl2=NHXzR2dUSU6JRWK=
ES7NUPsOIxoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NELMO5BKSzVyPUO0NU46QSCwTR?=NEHTVJRUSU6JRWK=
MDA-MB-175-VIIMonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGficHpKSzVyPUO1Nk46OiCwTR?=NX3L[HFQW0GQR1XS
GAMGM1H2Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\CV3BKSzVyPUO3NE45PSCwTR?=NVjnVG5CW0GQR1XS
CHL-1M3v2fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3PBN2lEPTB;M{e4MlY2KG6PNH71[VRUSU6JRWK=
NB7M4nnSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGXOfYtKSzVyPUO4PU45OyCwTR?=NXS0ZZZIW0GQR1XS
MFE-280MnrRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTRzOD6yJI5OM1Ppe3NCVkeHUh?=
HL-60M37kSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M360TmlEPTB;NEK1Mlc2KG6PMmfXV2FPT0WU
GCIYNX\scHJtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfyPVFnUUN3ME20N|MvQCCwTR?=NYPkOWR3W0GQR1XS
MDA-MB-361NXr5N3ppT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4nHWGlEPTB;NEO5MlE{KG6PNWru[o1tW0GQR1XS
LXF-289NG\KZYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\JXWVKSzVyPUS0PE4zPyCwTR?=NGHLPG5USU6JRWK=
NBsusSRMkDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILWVJhKSzVyPUS4PE45PSCwTR?=M1;MdHNCVkeHUh?=
KU-19-19NWDBRWJGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUPoTYkxUUN3ME21NVYvODdibl2=Mlj1V2FPT0WU
A204M{C4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7CTWM2OD13MkKuN|Mhdk1?MlnXV2FPT0WU
LB1047-RCCMn;HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2LNWGlEPTB;NUKyMlk{KG6PM3fV[HNCVkeHUh?=
COLO-684MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjEWFA5UUN3ME21NlMvOTFibl2=NH:0cIpUSU6JRWK=
PA-1MnPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTV|Mj60NUBvVQ>?NVrTcndMW0GQR1XS
MG-63NUTycYZXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzaTWM2OD13NEGuNVEhdk1?Mnu5V2FPT0WU
BHT-101NYTmd|gyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2jXZWlEPTB;NUS0Mlk1KG6PMnrQV2FPT0WU
NKM-1NWDnUZc5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;zXmNKSzVyPUW5N{4xQSCwTR?=MonlV2FPT0WU
T47DM1\ZUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\3folKSzVyPUW5O{42PiCwTR?=Mo\XV2FPT0WU
MOLT-4MlraS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXTxPIE5UUN3ME22NlMvPjJibl2=NX62SWd4W0GQR1XS
IGROV-1Mm\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LCWGlEPTB;NkO0MlMyKG6PMlLvV2FPT0WU
ES4M2DLTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvITWM2OD14M{muOVQhdk1?NXLSOlVIW0GQR1XS
HuO-3N1NFrVXmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1u4SmlEPTB;NkSyMlM5KG6PMWXTRW5ITVJ?
NEC8NFPUeWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXzOdGkxUUN3ME22OVMvPTdibl2=M1vnRnNCVkeHUh?=
HO-1-N-1NFrxOVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NITOToNKSzVyPU[1PU4yPyCwTR?=MVjTRW5ITVJ?
EPCL-272HMl;MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HQV2lEPTB;Nki3MlIyKG6PNV:3bWRRW0GQR1XS
D-263MGNGn1XVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFjiZ5RKSzVyPUexPE4yKG6PNHmzZnFUSU6JRWK=
MV-4-11NUfvV21MT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGftSnVKSzVyPUeyOE4{OSCwTR?=MnrsV2FPT0WU
SK-NEP-1NHnse2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYm0Omw6UUN3ME23NlUvQTRibl2=NWPhR|EzW0GQR1XS
SW872MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXnqRml2UUN3ME23NlcvQDlibl2=NH20SXZUSU6JRWK=
P30-OHKNYLPOXVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXnJRZRbUUN3ME23N|AvPzFibl2=MmPJV2FPT0WU
OMC-1MnzaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NETmdmVKSzVyPUe1NU4xQSCwTR?=MkHKV2FPT0WU
LoVoMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoK1TWM2OD15N{euPUBvVQ>?MXrTRW5ITVJ?
LNCaP-Clone-FGCM1;JUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWXJR|UxRTd7Nj6zOEBvVQ>?MYXTRW5ITVJ?
L-363MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF3qVXdKSzVyPUe5PE41OiCwTR?=MYXTRW5ITVJ?
ES8NVnTW3BUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2Hpb2lEPTB;OEGwMlUzKG6PNHXIOZZUSU6JRWK=
697M{\je2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGHyRYdKSzVyPUizNU42PSCwTR?=NFLYSJRUSU6JRWK=
HSC-3MlLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmLTTWM2OD16M{muOVQhdk1?MoTXV2FPT0WU
H4NWCxWodMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHNWFF1UUN3ME24OVAvQDVibl2=MmH1V2FPT0WU
QIMR-WILMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{HROGlEPTB;OE[1MlIhdk1?MlnOV2FPT0WU
OAW-42NH64PIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTh5Mj6xPUBvVQ>?MULTRW5ITVJ?
MCF7NUfxXmpPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlqwTWM2OD16OUiuOVkhdk1?NV\iT21TW0GQR1XS
SCC-25NI\ENoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnW2TWM2OD17MUSuNVkhdk1?NY\OSod2W0GQR1XS
NCI-H1563NILkPG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LsbGlEPTB;OUG1Mlk6KG6PNUfSbohMW0GQR1XS
OVCAR-5MmLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPOWlE{UUN3ME25OFAvOTdibl2=M4DsdXNCVkeHUh?=
HDLM-2Ml\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1O3c2lEPTB;OUS5MlIhdk1?NV2xXJU6W0GQR1XS
NB5M{jWOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGf1OYJKSzVyPUm1Ok43KG6PNVP5bJhWW0GQR1XS
NCI-H292M4PaWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWfVVYdSUUN3ME25O|QvOzJibl2=NXKxeHVyW0GQR1XS
A101DNFPu[IhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXaZnNKSzVyPUm5NE4yQSCwTR?=MofNV2FPT0WU
NCI-H1648MojoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHETWM2OD17OUiuOVEhdk1?NGDx[JlUSU6JRWK=
EKVXM3ixZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV\idlBnUUN3ME2xMlAyOjlizszNNXHO[lN1W0GQR1XS
SW1710NVvJSGJvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUXJR|UxRTFwMESyN|Mh|ryPNFfBW4ZUSU6JRWK=
WM-115NFS3cIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LwfGlEPTB;MT6wOlY2PiEQvF2=MlLZV2FPT0WU
CAL-54MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1m1VGlEPTB;MT6wO|A5OSEQvF2=MUfTRW5ITVJ?
TGBC24TKBMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVjJR|UxRTFwMEiwOFUh|ryPMUfTRW5ITVJ?
NCI-H520MojES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWm0U5FvUUN3ME2xMlA5QTZ5IN88US=>MYrTRW5ITVJ?
D-423MGMlTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33ne2lEPTB;MT6wPVk3OiEQvF2=NYDIcZZ1W0GQR1XS
BFTC-905MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWPyNHB3UUN3ME2xMlE{PDR7IN88US=>NVnheXNYW0GQR1XS
HTMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPsWJpKSzVyPUGuNVM1PzhizszNMm\3V2FPT0WU
CTB-1MmX0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2XTU2lEPTB;MT6xOFI6OyEQvF2=NULSNYo4W0GQR1XS
Hs-578-TMlrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\xTG5KSzVyPUGuNVk2PjVizszNNFXVWJVUSU6JRWK=
HuH-7MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHzIVGFKSzVyPUGuNlA6PDlizszNNGC3VY5USU6JRWK=
LB996-RCCNFLtSm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NETzNlFKSzVyPUGuNlIyPzdizszNM4m2T3NCVkeHUh?=
KYSE-270NHPL[otIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1m4eGlEPTB;MT6yPVc{PCEQvF2=MVvTRW5ITVJ?
A4-FukM4r1OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUnJR|UxRTFwMkm5PVMh|ryPNF;lWlRUSU6JRWK=
A498M2CzPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mor5TWM2OD1zLkOwOFc1KM7:TR?=NGK2RYhUSU6JRWK=
SK-MEL-1NXK5NJRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{TKPWlEPTB;MT6zNFY4QSEQvF2=NEf1RodUSU6JRWK=
AU565MmjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3j0XWlEPTB;MT6zNVg3OyEQvF2=NW\6TlJFW0GQR1XS
Saos-2Mn7GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYfJR|UxRTFwM{OyNFUh|ryPMoDrV2FPT0WU
A549MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmC3TWM2OD1zLkO5PVch|ryPM2f3[HNCVkeHUh?=
BFTC-909MoW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRTFwNEOzNFUh|ryPNFiwWo5USU6JRWK=
MDA-MB-415MoPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTFwNEi2PVIh|ryPNU[4bnh{W0GQR1XS
639-VM3[xNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojzTWM2OD1zLkWwNlQ2KM7:TR?=NEPsZYFUSU6JRWK=
A704NV:y[lhNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTFwNUC3PFUh|ryPNYHlRVg6W0GQR1XS
PANC-03-27NHPuTXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDDT3FpUUN3ME2xMlUyPDB6IN88US=>MmXLV2FPT0WU
SK-MEL-28MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1vlb2lEPTB;MT61OlA5PSEQvF2=NFrjUnBUSU6JRWK=
Ramos-2G6-4C10NELpOJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF36d4hKSzVyPUGuOlA4PDZizszNMnS4V2FPT0WU
HuP-T4NVHC[4FST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3jldmlEPTB;MT62NFc4QCEQvF2=MYLTRW5ITVJ?
VA-ES-BJNWXwe3h4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvvTHhIUUN3ME2xMlYyOjdizszNNVLGNGNIW0GQR1XS
EFM-19M2\j[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{WxNWlEPTB;MT62NVgyKM7:TR?=M3;2U3NCVkeHUh?=
G-401NFvIU4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnHWGpKSzVyPUGuOlIyPjRizszNMUXTRW5ITVJ?
D-566MGMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoLYTWM2OD1zLk[yOVMh|ryPMV7TRW5ITVJ?
JVM-3MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTJR|UxRTFwNkS4O|Uh|ryPM1\kS3NCVkeHUh?=
TK10M2PNdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH7SSIZKSzVyPUGuOlcxQDNizszNNGHkSmpUSU6JRWK=
BT-20M3O1Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnjVTWM2OD1zLk[4PVAzKM7:TR?=MVLTRW5ITVJ?
EGI-1M2LCfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVXKeGFwUUN3ME2xMlg1PzBzIN88US=>MYnTRW5ITVJ?
EW-16NXPhd4xWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2D6d2lEPTB;MT64OVE5OiEQvF2=MkDQV2FPT0WU
NCI-H2228NEXQbFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofITWM2OD1zLki1NlA{KM7:TR?=M2TQcXNCVkeHUh?=
BB49-HNCMlrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M13hR2lEPTB;MT64PFY6OiEQvF2=NFPBRlNUSU6JRWK=
G-402NIPBXGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLETWM2OD1zLki5O|k4KM7:TR?=NHn1S2dUSU6JRWK=
NCI-H526NFLSVYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkDCTWM2OD1zLkmxN|kh|ryPMVfTRW5ITVJ?
ME-180MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXzJR|UxRTFwOUO0O|ch|ryPNGTkeGhUSU6JRWK=
PFSK-1NHzCfHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3e4VmlEPTB;MT65OFQ2QCEQvF2=M3zGSHNCVkeHUh?=
TYK-nuNGjQSW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4HHS2lEPTB;MT65OVgzOyEQvF2=NHvkZVhUSU6JRWK=
HOSNYS0bnZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrDTWM2OD1zLkm3PVQ5KM7:TR?=NXTBTGI4W0GQR1XS
T98GM1jUdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXRco5wUUN3ME2xMlk6ODB4IN88US=>M2PLSHNCVkeHUh?=
SK-MES-1NXLpdZVLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGLET|dKSzVyPUKuNFE{OzJizszNM4LEenNCVkeHUh?=
SNB75M3;NSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NI\4WmJKSzVyPUKuNFE2PDFizszNNICwZ3ZUSU6JRWK=
LAMA-84NELVZ5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYHJR|UxRTJwMEK2PFkh|ryPNEDYTG9USU6JRWK=
CAL-39M3XocGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYPJR|UxRTJwMEOyPEDPxE1?MnT0V2FPT0WU
LOXIMVIM3v6UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkfqTWM2OD1{LkC0NFg1KM7:TR?=Mm\BV2FPT0WU
NH-12M4CzVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYnVemlYUUN3ME2yMlA2PDJ2IN88US=>NXrjO4dvW0GQR1XS
NCI-H1048M4i0fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnhbJA6UUN3ME2yMlExPTJizszNNETMempUSU6JRWK=
KS-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\yVmlEPTB;Mj6xNVAxOSEQvF2=NILLdHFUSU6JRWK=
NCI-N87NHLnbY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWXwV2lCUUN3ME2yMlE{Ozh2IN88US=>M4DnOXNCVkeHUh?=
CHP-212M2HXcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIi2cYtKSzVyPUKuNVg1PDJizszNNF32N5dUSU6JRWK=
HCC1419NWntUYhNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XKWmlEPTB;Mj6yNVEyPSEQvF2=M4TqUXNCVkeHUh?=
ES1NFrqOoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTJwMkGzNlYh|ryPMmTVV2FPT0WU
NCI-H2030MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVHJR|UxRTJwMkSxNlMh|ryPMkf6V2FPT0WU
EW-22M3\5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnPGTWM2OD1{LkK1NFY4KM7:TR?=M4TrSHNCVkeHUh?=
A431MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTJwMkezOVQh|ryPNV;FWlY2W0GQR1XS
SF126MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIPRXphKSzVyPUKuN|A3OjVizszNMXjTRW5ITVJ?
SF295MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYLJR|UxRTJwM{G1NlQh|ryPNGXhUJFUSU6JRWK=
D-502MGNV;J[GY2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnX1TWM2OD1{LkOyOFYyKM7:TR?=NF3JN41USU6JRWK=
HCC2157MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTJwM{K5Nlch|ryPMnj2V2FPT0WU
D-283MEDMoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUXld2RVUUN3ME2yMlM2QTJ4IN88US=>MUjTRW5ITVJ?
SNU-423MkDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnTaTWM2OD1{LkSwNVcyKM7:TR?=MYfTRW5ITVJ?
SK-LU-1MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYracFRlUUN3ME2yMlQ1PTh4IN88US=>M2HkWXNCVkeHUh?=
22RV1M2O2[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWjDXGRyUUN3ME2yMlQ2PjF5IN88US=>M{CxRXNCVkeHUh?=
SW1088NUnYe25lT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnPWpJpUUN3ME2yMlQ6OjF|IN88US=>MV\TRW5ITVJ?
HT-3M1HaVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF35bYZKSzVyPUKuOFkzPTlizszNNWe2eWZFW0GQR1XS
NCI-H1666MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWfJR|UxRTJwNUGxNFQh|ryPMUHTRW5ITVJ?
EM-2MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETZTmJKSzVyPUKuOVEyPjlizszNMonQV2FPT0WU
SNU-449NUH6SpUyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWDJR|UxRTJwNUewNVQh|ryPNXnRO3hYW0GQR1XS
786-0NFHtUoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTJwNUmyN|gh|ryPMlfwV2FPT0WU
SKG-IIIaNH[0VJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmXITWM2OD1{Lk[1PVM6KM7:TR?=MmGzV2FPT0WU
MEL-HOMlj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV\GfYppUUN3ME2yMlY4PjN2IN88US=>MVLTRW5ITVJ?
LCLC-97TM1NF64eYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HkNmlEPTB;Mj62PVI3PyEQvF2=NHjoNFhUSU6JRWK=
MKN7M4jUZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFzlNVBKSzVyPUKuO|A4PTRizszNNWXncpVUW0GQR1XS
5637MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml7pTWM2OD1{LkexNFM2KM7:TR?=NVXaSpM5W0GQR1XS
HOP-92MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTJwN{S3NVch|ryPMUfTRW5ITVJ?
MDA-MB-157MkK4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml\CTWM2OD1{LkiyNFI{KM7:TR?=NGW3[lZUSU6JRWK=
NB12NYXMcXV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3HLSmlEPTB;Mj64OFkyPCEQvF2=MnvkV2FPT0WU
DMS-273MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2D5NWlEPTB;Mj64OlQ4KM7:TR?=NXe3emY{W0GQR1XS
HCC70MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1j1fmlEPTB;Mj64OlU5QSEQvF2=NY\TfW43W0GQR1XS
YKG-1NVu0eI9sT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlLHTWM2OD1|LkCzO|g4KM7:TR?=M4j4THNCVkeHUh?=
NCI-H28NWHvU4JQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moq0TWM2OD1|LkC1NlkyKM7:TR?=MUHTRW5ITVJ?
HNMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;jUFFKSzVyPUOuNFY3OzZizszNM1;iXHNCVkeHUh?=
HT-1080MlHHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HhfmlEPTB;Mz6wPFYxPiEQvF2=NHXnOYFUSU6JRWK=
HPAF-IIM1e5T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHrDOWRKSzVyPUOuNVAxPjhizszNNFzsW3VUSU6JRWK=
U-2-OSNIKwSYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjTOWhKSzVyPUOuNVM4QDJizszNMlG3V2FPT0WU
SNU-387MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFXLSmlKSzVyPUOuNVY{PjRizszNMmHHV2FPT0WU
BeckerNGHEfm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH;LZVdKSzVyPUOuNVY5ODhizszNNFHEPHZUSU6JRWK=
BHYNEf5foRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33pOGlEPTB;Mz6yOVU4OSEQvF2=NHnX[ItUSU6JRWK=
HTC-C3M2fuWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX63dlFSUUN3ME2zMlI6OzV{IN88US=>NV\IPJF5W0GQR1XS
M14NF;xc2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTNwM{C2OlMh|ryPNUTB[mRKW0GQR1XS
COR-L23NF7ISGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTNwM{eyO|kh|ryPMUPTRW5ITVJ?
C32NYrC[IhmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTNwNEG1NFgh|ryPM3ruW3NCVkeHUh?=
MewoNXHObpRWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTNwNEKxPFIh|ryPNWHZ[ZQ6W0GQR1XS
TE-8MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17DWGlEPTB;Mz60PFI2QSEQvF2=NWPKNplPW0GQR1XS
RPMI-2650NVnkdYpnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWjSRWZUUUN3ME2zMlYxPjN5IN88US=>MW\TRW5ITVJ?
AGSMlLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn6yTWM2OD1|Lk[yOFY1KM7:TR?=NYL4dVNCW0GQR1XS
MZ2-MELM2HtSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mmf5TWM2OD1|Lk[2NVM5KM7:TR?=MnvtV2FPT0WU
Calu-3NWW3dndwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\ZTWM2OD1|LkexNlg4KM7:TR?=NFflT4FUSU6JRWK=
SJSA-1MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nCTWlEPTB;Mz63NVMyPSEQvF2=MmjaV2FPT0WU
SW962NUjNZYhQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHGTWM2OD1|LkeyOlM3KM7:TR?=M1vaenNCVkeHUh?=
PC-14NITSSYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWPJR|UxRTNwN{OyNlIh|ryPM3vBeXNCVkeHUh?=
SW1573NIjIXIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYD6dZRRUUN3ME2zMlc2OzR6IN88US=>MmrQV2FPT0WU
769-PNFfPe5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvsVI1KSzVyPUOuPFI4PDNizszNM2roRXNCVkeHUh?=
KNS-62NWrVempLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13YV2lEPTB;Mz65NlM{QCEQvF2=NUfFPYI6W0GQR1XS
NCI-H747M4O0Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXrJR|UxRTRwMEW2N|gh|ryPNX;Gfos1W0GQR1XS
LN-405NV7Gc4VxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFXNdlVKSzVyPUSuNVU4OjhizszNMXXTRW5ITVJ?
OVCAR-8Ml\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV;JR|UxRTRwMkK1OFMh|ryPNGq5So1USU6JRWK=
DMS-114Mn3ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFvFXVJKSzVyPUSuNlM5QTFizszNMWTTRW5ITVJ?
NCI-H2126MlfaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmD4TWM2OD12LkK0OVU5KM7:TR?=M1ThRXNCVkeHUh?=
TCCSUPMnmwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NELxVm1KSzVyPUSuNlQ4QDhizszNM33COXNCVkeHUh?=
SK-N-FIM2WwO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlf2TWM2OD12LkK1N|MzKM7:TR?=MXzTRW5ITVJ?
HCE-4NIfSRnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF6zdmZKSzVyPUSuNlcyQTdizszNNVTWT5VZW0GQR1XS
DK-MGNFnU[HhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIe5Tm9KSzVyPUSuN|A{QSEQvF2=NHPR[pFUSU6JRWK=
RO82-W-1NHG1PGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\4NWlEPTB;ND6zNlU5PCEQvF2=NYW4UGtPW0GQR1XS
A2780NVTEXmtnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFX4eGpKSzVyPUSuN|Y3QDJizszNNWiyUIhUW0GQR1XS
ETK-1M{S4TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\1cWlEPTB;ND6zO|A2OiEQvF2=NY\EXFZQW0GQR1XS
FADUMkTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fHdmlEPTB;ND6zO|Q3PyEQvF2=MmnRV2FPT0WU
CAL-12TNGf0VG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1rWXWlEPTB;ND60NVQyOyEQvF2=NUTmXJpjW0GQR1XS
647-VM2LqdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MknITWM2OD12LkS0NFIzKM7:TR?=MVjTRW5ITVJ?
TGBC1TKBMl32S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWPJR|UxRTRwNEWxNVMh|ryPNXHDVnZCW0GQR1XS
LU-99AMmX3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLxUFhKSzVyPUSuOFYxPiEQvF2=M1fsWHNCVkeHUh?=
CAL-33M4j2Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGniO3pKSzVyPUSuOVI1PTZizszNMkj3V2FPT0WU
LU-134-ANHnKOnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHzzT4NKSzVyPUSuOVI4PDVizszNM3fwfnNCVkeHUh?=
NCI-H1355NHjHPIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVvJR|UxRTRwNUWxOFYh|ryPMnzYV2FPT0WU
RPMI-7951MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUjLeGJsUUN3ME20MlU4ODB{IN88US=>M4jpfHNCVkeHUh?=
TE-1MoTkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojsTWM2OD12Lk[2NVQ{KM7:TR?=MYPTRW5ITVJ?
OE33MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MknaTWM2OD12LkewOVEyKM7:TR?=MnzUV2FPT0WU
CAL-51NGDUXXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1zFU2lEPTB;ND63NVA5OiEQvF2=NWf4SZlIW0GQR1XS
SW1783NVzvZZVyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHHiU4FKSzVyPUSuO|U{ODhizszNMYrTRW5ITVJ?
BT-474NIm2R|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXPJR|UxRTRwN{[zPFQh|ryPNFj5XFdUSU6JRWK=
KYSE-520MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2KxU2lEPTB;ND64O|M6OiEQvF2=NVzoPYd7W0GQR1XS
8-MG-BAM4DofGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoryTWM2OD12Lki4OVU4KM7:TR?=Mm\FV2FPT0WU
IA-LMMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnTQTWM2OD12Lkm5OFM2KM7:TR?=MknKV2FPT0WU
SW954M1zKWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHLwcnNKSzVyPUSuPVk1PDNizszNMWLTRW5ITVJ?
RPMI-8226MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkW0TWM2OD13LkC1OFYyKM7:TR?=NIO5[XpUSU6JRWK=
MKN1NVrucGxGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TQbmlEPTB;NT6wO|kzPyEQvF2=MU\TRW5ITVJ?
A375NXqxPJdlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2O5XWlEPTB;NT6wPVI2PiEQvF2=NIX3TYlUSU6JRWK=
8305CM4nZcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTVwMEm4PFch|ryPMlvDV2FPT0WU
CAL-62MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHTTWM2OD13LkG4NlU6KM7:TR?=NG\1V3FUSU6JRWK=
NB10MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVPJR|UxRTVwMkK3OFQh|ryPNU\YVXpHW0GQR1XS
OC-314M{\3dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTVRlVKSzVyPUWuN|c1PDRizszNMUnTRW5ITVJ?
PSN1NFnJdpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH7GOYlKSzVyPUWuN|gzQDZizszNM{T1VHNCVkeHUh?=
GR-STMnTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWC4T286UUN3ME21MlM5OzJ{IN88US=>NIfwRW5USU6JRWK=
P12-ICHIKAWAMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTJR|UxRTVwNECxJO69VQ>?NIL5Z3BUSU6JRWK=
NCI-H1092M4rvPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH;xcVlKSzVyPUWuOFEyPDhizszNMV\TRW5ITVJ?
SCC-4NYPETVFST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFHt[GRKSzVyPUWuOFE{PTVizszNM1XmVHNCVkeHUh?=
TE-6M4fXVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;tS2lEPTB;NT60NVgyPiEQvF2=MmXLV2FPT0WU
DOHH-2MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;1bXJyUUN3ME21MlQzOjR6IN88US=>NWn1b3ZTW0GQR1XS
SW684NHHaXlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm\LTWM2OD13Lk[2N|g2KM7:TR?=MWTTRW5ITVJ?
CP50-MEL-BMmi4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3Pwb2lEPTB;NT62PFY5PCEQvF2=M4ntZ3NCVkeHUh?=
UM-UC-3MlPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEe1WlNKSzVyPUWuO|IzOzFizszNNIrxRnJUSU6JRWK=
LC-2-adNYPlXYN7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRTVwN{iyOVEh|ryPMmD1V2FPT0WU
PC-3MnTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2Xid2lEPTB;NT65NVYyPSEQvF2=MX;TRW5ITVJ?
CANNELwV2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXTTWM2OD13LkmyPFIh|ryPM2fvZnNCVkeHUh?=
ESS-1M1H4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXLJR|UxRTVwOUe4Olkh|ryPMoT0V2FPT0WU
ATN-1NX;KRXg3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkmwTWM2OD14LkC1OVY5KM7:TR?=MUHTRW5ITVJ?
BxPC-3MnvPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTZwMEiyNVkh|ryPMnrXV2FPT0WU
KYSE-150M{S2Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrhV4VKSzVyPU[uNVI1PzZizszNM{PnNXNCVkeHUh?=
RPMI-8866NH\zdXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXzhc3B[UUN3ME22MlE6OTZ|IN88US=>M2mzTnNCVkeHUh?=
SW780NIPoUFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTZwMkC0NkDPxE1?M4jXNXNCVkeHUh?=
A388MoO5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoTBTWM2OD14LkKzNVE2KM7:TR?=M1X3O3NCVkeHUh?=
NCI-H1437NUK3SWg3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmfjTWM2OD14LkK0NFc{KM7:TR?=M4npbXNCVkeHUh?=
NCI-H1755NEfhUXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1fMTGlEPTB;Nj6zOlYyOiEQvF2=M2D5NXNCVkeHUh?=
LS-123M3\xWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYDLNphnUUN3ME22MlQxPTJzIN88US=>NFrM[nhUSU6JRWK=
CaR-1NH:2SY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTZwNE[zO|Mh|ryPNH\YOnVUSU6JRWK=
RT-112MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3ftWmlEPTB;Nj62NFM{QCEQvF2=MUDTRW5ITVJ?
CGTMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4f1UmlEPTB;Nj63N|Y5OSEQvF2=NXWwPIh2W0GQR1XS
SW626MorIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoizTWM2OD14LkezPVQ3KM7:TR?=MnOwV2FPT0WU
AsPC-1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTZwN{S1NFch|ryPMoDSV2FPT0WU
SBC-5NWXvOphtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NELDPXNKSzVyPU[uPVczQTdizszNMUHTRW5ITVJ?
SF539M3jLZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX62bml6UUN3ME22Mlk6OzN|IN88US=>MYjTRW5ITVJ?
TI-73M1ThO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFT1PJhKSzVyPUeuNFYzQDVizszNNHHJcYNUSU6JRWK=
MHH-ES-1MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkO1TWM2OD15LkC3O|YzKM7:TR?=NGjm[mhUSU6JRWK=
KYSE-510NWD2XZB[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTdwMEi0N|Ih|ryPNH76O41USU6JRWK=
EW-1NEPGeXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLmTWM2OD15LkO2PVk3KM7:TR?=M1ry[HNCVkeHUh?=
SK-OV-3M1jRd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYS1bGNsUUN3ME23MlM6PDN{IN88US=>M{LOS3NCVkeHUh?=
MC-IXCNUDGUJpWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWXJR|UxRTdwNEG5O|Ih|ryPNUfnXmJCW0GQR1XS
HSC-2M4T0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoDrTWM2OD15LkSyO|A2KM7:TR?=M3;oOHNCVkeHUh?=
NCI-H2342NUDQeIdiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4HQXWlEPTB;Nz61NVQ6KM7:TR?=Mly2V2FPT0WU
NCI-H1792NF36RY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYL2dolkUUN3ME23MlUyPzFzIN88US=>NVLUXlBmW0GQR1XS
HT-1376M2nWbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:1d2c1UUN3ME23Mlg4Pzd6IN88US=>MYXTRW5ITVJ?
EW-13NVy0e2hGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{exTWlEPTB;Nz64PVk4PyEQvF2=Mn\FV2FPT0WU
no-11MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWTJR|UxRTdwOUCxO|Qh|ryPNVLzOYJzW0GQR1XS
DaoyNYTWSHloT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2e5NWlEPTB;Nz65OFMzOSEQvF2=NXfVSIZ7W0GQR1XS
COLO-800MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nWSmlEPTB;OD6wOFE3OiEQvF2=NFLNcYFUSU6JRWK=
GB-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoW4TWM2OD16LkC2OVY2KM7:TR?=MVvTRW5ITVJ?
SJRH30NXqwOZlET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWG4d2szUUN3ME24MlE2QDd6IN88US=>NGHOU5lUSU6JRWK=
NCI-H2291MoDWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHfOZoVKSzVyPUiuNlkyQDdizszNMVLTRW5ITVJ?
J82NEnqTWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3Pn[2lEPTB;OD6yPVQ6OSEQvF2=MlvpV2FPT0WU
NCI-H596NHW3SlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRThwM{G0OVMh|ryPNF3yW5JUSU6JRWK=
RERF-LC-MSNGrtfWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnTnTWM2OD16LkO0PFU3KM7:TR?=NX6zRWk4W0GQR1XS
RH-18M2LO[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfUe2lKSzVyPUiuN|UxPDZizszNMn\KV2FPT0WU
SW48NFL6OlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXabZRKSzVyPUiuOVk1PTNizszNNXnjcHlbW0GQR1XS
RDMWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13ETGlEPTB;OD61PVM6OSEQvF2=M4L1U3NCVkeHUh?=
MS-1M3vJ[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHkTWM2OD16Lk[xN|g4KM7:TR?=M1S5VXNCVkeHUh?=
ES6MkLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzYVVhKSzVyPUiuO|MyOTlizszNMVfTRW5ITVJ?
TE-12MkT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2HEN2lEPTB;OD63O|UxPSEQvF2=NWKyWmk1W0GQR1XS
DBTRG-05MGM4\YOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmDnTWM2OD16LkmxNlE4KM7:TR?=Ml;mV2FPT0WU
KINGS-1M4PHZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRThwOUK5N|gh|ryPMkHDV2FPT0WU
HLEMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRThwOUO3PFUh|ryPMX7TRW5ITVJ?
MHH-NB-11MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnz3TWM2OD17LkCxPFM6KM7:TR?=NVW4SmVJW0GQR1XS
U-87-MGM37QSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4T3cmlEPTB;OT6yOFMzOSEQvF2=MXTTRW5ITVJ?
MN-60M4Hxd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXzXOpI5UUN3ME25MlI1PTR{IN88US=>NH7tRY1USU6JRWK=
SASMkTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1rTVmlEPTB;OT6yOVU5OSEQvF2=M1XyPXNCVkeHUh?=
NCI-H446MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn64TWM2OD17LkO2NUDPxE1?NYfSdW84W0GQR1XS
C-33-AMkDpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXm0cIdvUUN3ME25MlQ{QTh6IN88US=>NVjQXnI2W0GQR1XS
RXF393NYPNN245T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3fNWmlEPTB;OT60O|AxOiEQvF2=MUXTRW5ITVJ?
CGTH-W-1MonIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1\jWWlEPTB;OT60PVM5PCEQvF2=MnPYV2FPT0WU
RCM-1M2ewUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUnISHBMUUN3ME25MlY{QDBzIN88US=>NUXGdJJ1W0GQR1XS
SN12CM13abWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TtW2lEPTB;OT62OVM{QCEQvF2=M{LJd3NCVkeHUh?=
KLEM1iwRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1jYTGlEPTB;OT63NFAxQSEQvF2=NYHTNIZQW0GQR1XS
EFO-21M2iyU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEnyR|FKSzVyPUmuO|c{QDJizszNMVHTRW5ITVJ?
KYSE-70NYHOWGhwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MorqTWM2OD17Lki4NFEyKM7:TR?=Mnn2V2FPT0WU
D-247MGNGjxUnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTFyLkC1Olgh|ryPMlnSV2FPT0WU
MPP-89Mln2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;0PZgzUUN3ME2xNE4xQTR4IN88US=>MV7TRW5ITVJ?
RVH-421MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFflN4NKSzVyPUGwMlE2ODVizszNMni5V2FPT0WU
NCI-H460M37ic2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MV;JR|UxRTFyLkK4NFYh|ryPMVvTRW5ITVJ?
NOMO-1NVG2eYZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkD4TWM2OD1zMD6zOVMzKM7:TR?=MlqyV2FPT0WU
DELMXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUPSeopmUUN3ME2xNE4{Pzl2IN88US=>NHfHb5VUSU6JRWK=
HT55NG\4THBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHXoVWNKSzVyPUGwMlYzODVizszNMkHaV2FPT0WU
MC116NE\Hd2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1nafGlEPTB;MUCuOlY2PSEQvF2=MYPTRW5ITVJ?
BB30-HNCM3vnPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn\uTWM2OD1zMD62Olkh|ryPNWHpZ2hkW0GQR1XS
DJM-1NHf5S|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\JTWM2OD1zMD62PVQ6KM7:TR?=NHXMV49USU6JRWK=
ZR-75-30M320d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPFTWM2OD1zMD65OFQyKM7:TR?=Mmn3V2FPT0WU
U-118-MGNEDSbJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvtOYdbUUN3ME2xNE46QDl4IN88US=>MnjiV2FPT0WU
MSTO-211HNWrBXFVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MonjTWM2OD1zMT6wO|E3KM7:TR?=NX7LWnZoW0GQR1XS
SW837M4fPOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVrwOGpFUUN3ME2xNU4xQTR7IN88US=>M2[zVHNCVkeHUh?=
HuCCT1M2fCPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1PQd2lEPTB;MUGuNVI5OSEQvF2=MXrTRW5ITVJ?
RCC10RGBMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2OyWGlEPTB;MUGuNVM2KM7:TR?=NWDyWJRQW0GQR1XS
NMC-G1M4m3emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHWTWM2OD1zMT6xOFk{KM7:TR?=MUDTRW5ITVJ?
NCI-H650MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTFzLkO3PVQh|ryPNF\mZ2xUSU6JRWK=
HEC-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoDXTWM2OD1zMT60N|I5KM7:TR?=NIi1fZpUSU6JRWK=
DU-4475NILmWHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjnN|RKSzVyPUGxMlc{QTNizszNNXuybGw{W0GQR1XS
DSH1NIrISINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M130cGlEPTB;MUGuO|YxPiEQvF2=NHTafolUSU6JRWK=
HCC1569NEjScY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUGySlBwUUN3ME2xNU44Pjd6IN88US=>NUXXO3F5W0GQR1XS
HCC1187NYrxZ3lsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofzTWM2OD1zMT64OVg5KM7:TR?=MUfTRW5ITVJ?
EW-11NEn2UVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1j5dGlEPTB;MUGuPVQ4PCEQvF2=NXPTR|hSW0GQR1XS
LB2518-MELMoLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFLKfZpKSzVyPUGyMlA2QSEQvF2=MVHTRW5ITVJ?
KALS-1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIe1UmtKSzVyPUGyMlg2PTNizszNNGf3fWRUSU6JRWK=
8505CMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnvtTWM2OD1zMj64PFUh|ryPM36xSHNCVkeHUh?=
SK-N-DZMlThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUHTXnJLUUN3ME2xN{4xPDV|IN88US=>M1m5cXNCVkeHUh?=
CHP-134NFzMU5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mn7jTWM2OD1zMz6xNVU5KM7:TR?=NHTweXRUSU6JRWK=
HCE-TMVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13lPGlEPTB;MUOuNlM3PCEQvF2=M1W1fnNCVkeHUh?=
LB-831-BLCMl7zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHtdXZrUUN3ME2xN{43OjR4IN88US=>NUDBR5lUW0GQR1XS
OVCAR-4NXnmWolRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LhT2lEPTB;MUOuOlUzPCEQvF2=MVPTRW5ITVJ?
SW756NHjMUpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MojSTWM2OD1zMz63NlQ3KM7:TR?=MYjTRW5ITVJ?
OCUB-MNWjZO3AyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGLuNHlKSzVyPUGzMlgyPTZizszNMW\TRW5ITVJ?
SW982MnjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7GXlF7UUN3ME2xN{45Ojd4IN88US=>NF:2fZNUSU6JRWK=
DBMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3\nbmlEPTB;MUOuPFM5PCEQvF2=NVrxe5JrW0GQR1XS
H-EMC-SSMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTF|LkmxN|kh|ryPNF3X[YZUSU6JRWK=
VMRC-RCZNUnqNpVWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHVXHdKSzVyPUG0MlAxOTVizszNNV3TRm9JW0GQR1XS
CAKI-1MliwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUTJR|UxRTF2LkCxN|Ih|ryPMX;TRW5ITVJ?
GI-1MlHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvRRnRKSzVyPUG0MlA3PThizszNNWK5WGlLW0GQR1XS
Ca9-22NVzKfHF[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmS5TWM2OD1zND62NFU1KM7:TR?=NWPCWnF6W0GQR1XS
TE-5M{jDcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\CeYdKSzVyPUG0MlczODhizszNMVnTRW5ITVJ?
EFO-27M1LXT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmL2TWM2OD1zND63OlIzKM7:TR?=MXPTRW5ITVJ?
CAL-72NHLZbpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH3CTWNKSzVyPUG0Mlc4QDNizszNNXPtSHN1W0GQR1XS
GP5dMoHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYDJR|UxRTF3LkC0O|Qh|ryPNF3idmpUSU6JRWK=
CAS-1MmixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIfDVHlKSzVyPUG1MlA3PiEQvF2=MUnTRW5ITVJ?
A2058MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DEVGlEPTB;MUWuOVY{QCEQvF2=M1ztTnNCVkeHUh?=
PANC-08-13NVTvRnhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHLKc2dKSzVyPUG1MlY5PTlizszNM4\2T3NCVkeHUh?=
Detroit562NXzxO|BST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXPJR|UxRTF3LkmxN|kh|ryPNUnC[lF{W0GQR1XS
PANC-10-05MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVjxeZBLUUN3ME2xOk4xQDJzIN88US=>MoL4V2FPT0WU
KOSC-2NVrKd5NvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX\JR|UxRTF4LkGxNlUh|ryPM3q4XHNCVkeHUh?=
GT3TKBNHjyUmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTF4LkG5PFEh|ryPMl;LV2FPT0WU
KM-H2MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTF4LkO2OFYh|ryPNVm4Xo4yW0GQR1XS
LB771-HNCM4rv[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LsfWlEPTB;MU[uOFQzOiEQvF2=NYDjPWlyW0GQR1XS
SF268M3TsNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHpT3BWUUN3ME2xOk41PTJizszNNWr3Opd4W0GQR1XS
OE19NX;UO4NQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\IU|VtUUN3ME2xOk42OjRizszNM1fsOnNCVkeHUh?=
MLMANVjyTWlqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX\UVYtxUUN3ME2xOk42PTdzIN88US=>NEPxNZRUSU6JRWK=
MDA-MB-231M2rKTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXIXm5HUUN3ME2xOk44OTN4IN88US=>NHWzbnFUSU6JRWK=
TGWNFvuNVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGm0bWlKSzVyPUG2MlgyODJizszNM2i3cnNCVkeHUh?=
MDA-MB-453MmXsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEK3UFJKSzVyPUG3MlAxODNizszNNYjCTY97W0GQR1XS
SNU-C2BNF\zU|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTF5LkCyN|ch|ryPNU\s[mczW0GQR1XS
A427MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTETWM2OD1zNz6yN|M1KM7:TR?=M3vaWHNCVkeHUh?=
SK-MEL-2MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVS5dYZDUUN3ME2xO{4{OjF|IN88US=>MXfTRW5ITVJ?
KURAMOCHINFvHcGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVjLZVd1UUN3ME2xO{4{QDl5IN88US=>Mk\uV2FPT0WU
IST-MEL1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml2zTWM2OD1zNz65NVgzKM7:TR?=MXrTRW5ITVJ?
NCI-H1793MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYnJR|UxRTF6LkG1PFEh|ryPMnjGV2FPT0WU
HCC1395NIL3d3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2DlPWlEPTB;MUiuOVYyOSEQvF2=MULTRW5ITVJ?
NUGC-3NVe3cWE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXzJR|UxRTF6Lk[1PFQh|ryPNF7CTIZUSU6JRWK=
BB65-RCCNH\tT3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1HDS2lEPTB;MUiuOlY6KM7:TR?=M2DhcnNCVkeHUh?=
RMG-INEPIbW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVjJR|UxRTF6LkezPFIh|ryPMVrTRW5ITVJ?
LS-513MnHKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;kN4tOUUN3ME2xPE46OjJ6IN88US=>NUHofFVrW0GQR1XS
MFM-223MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vrRWlEPTB;MUmuNFcyPiEQvF2=MnryV2FPT0WU
NCI-H727Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFOwbnhKSzVyPUG5MlMzQTVizszNNUfaS4tiW0GQR1XS
KP-4NFLjb4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NE\GeW1KSzVyPUG5Mlg2OzFizszNMmHNV2FPT0WU
NB13Ml:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mln3TWM2OD1zOT64PFM6KM7:TR?=NInTbIFUSU6JRWK=
UACC-893MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF:5VFlKSzVyPUG5Mlk4PTdizszNMW\TRW5ITVJ?
HT-1197MoPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPQTWM2OD1{MD6yPVU5KM7:TR?=NH64e29USU6JRWK=
NCI-H2029NUPvPJI2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVjyUGlnUUN3ME2yNE4{OjZ4IN88US=>MX7TRW5ITVJ?
GI-ME-NNYDSSFBTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2i0fWlEPTB;MkCuN|M4OyEQvF2=M{X3XXNCVkeHUh?=
OVCAR-3NWPDd2dbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDKdZkzUUN3ME2yNE42QDJ{IN88US=>Mo\jV2FPT0WU
HD-MY-ZNY\jPHZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXLWGlKSzVyPUKxMlM3QTZizszNMXvTRW5ITVJ?
NTERA-S-cl-D1NYXRT2UyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV3JR|UxRTJzLk[3NlIh|ryPNHLKdGFUSU6JRWK=
SCHMn2yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEjDcohKSzVyPUKyMlQ6PiEQvF2=M1PaWXNCVkeHUh?=
KARPAS-299MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7VN4dKSzVyPUKzMlM5QDdizszNMlLHV2FPT0WU
NCI-H1650MoXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlO5TWM2OD1{Mz65NlQyKM7:TR?=NU\xR|dHW0GQR1XS
ACHNNUj4dXRzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRTJ2LkS2OVYh|ryPMnjQV2FPT0WU
M059JMoS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVnFRWN4UUN3ME2yOE42PjN2IN88US=>NICzbGZUSU6JRWK=
AM-38NXjWUIV5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3zOcmlEPTB;MkWuOFgyKM7:TR?=MmrKV2FPT0WU
KG-1NF3a[mpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\DTWM2OD1{NT61OFk1KM7:TR?=MXHTRW5ITVJ?
COLO-824M{j0RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7qTWM2OD1{NT61OVk6KM7:TR?=MVPTRW5ITVJ?
NCI-H1155M2HEXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWLJR|UxRTJ3LkW4OFch|ryPMoTMV2FPT0WU
NCI-H441NFfUZYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmTUTWM2OD1{NT63OFY2KM7:TR?=M1jJPXNCVkeHUh?=
J-RT3-T3-5NXLER3k3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HCemlEPTB;Mk[uN|AzPyEQvF2=MXfTRW5ITVJ?
JEG-3MnyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnYTWM2OD1{Nj62PFA2KM7:TR?=NVmwSHFlW0GQR1XS
RKONHLt[GxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTJ4Lke2N|Ih|ryPM1XocXNCVkeHUh?=
CAL-85-1NX3aTmY{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVjJR|UxRTJ5LkKxNVgh|ryPNVnKU|dEW0GQR1XS
CAL-120MkL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYe3cI4{UUN3ME2yO{43QTF2IN88US=>M{DwdXNCVkeHUh?=
NCI-H2452M3rtR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{H0ZWlEPTB;MkeuO|cyPiEQvF2=NHS3[|lUSU6JRWK=
NCI-H1395NV7zdlJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYjJR|UxRTJ5Lke4N|Mh|ryPMnXqV2FPT0WU
KYSE-450NUO5R3ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIPSXHpKSzVyPUK3Mlk5PjJizszNM{DLVXNCVkeHUh?=
S-117MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoHqTWM2OD1{OT6zPFU4KM7:TR?=MU\TRW5ITVJ?
SW13M2PqT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILWUo9KSzVyPUK5Mlg2OTlizszNNEHNWIFUSU6JRWK=
ES3NUTOeHpFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTNyLkO3N|Mh|ryPNXO4[HhXW0GQR1XS
HCT-116MkjoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV3DT5pzUUN3ME2zNE42PTV2IN88US=>NVvxUWFCW0GQR1XS
NCI-H1693M3rjWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnBTWM2OD1|MD61PVQzKM7:TR?=M1jIVnNCVkeHUh?=
VM-CUB-1M4[4dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTxfI8yUUN3ME2zNE43PDF|IN88US=>NInGe|JUSU6JRWK=
NCI-H2170M4LJXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4jwOWlEPTB;M{GuOVc5PCEQvF2=MXvTRW5ITVJ?
ALL-POM3vBV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTNzLki0Nlgh|ryPNYG5d4FlW0GQR1XS
NCI-H661M{TIOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPtfXZOUUN3ME2zNk4xPjJ|IN88US=>MXzTRW5ITVJ?
NCI-H2347M2CwXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:2Z3h4UUN3ME2zNk41QDN5IN88US=>NHzQSIpUSU6JRWK=
FTC-133MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnS4TWM2OD1|Mj63NFYh|ryPMmG1V2FPT0WU
COLO-829NVLjNJNET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlf4TWM2OD1|Mz6zOFY4KM7:TR?=MYfTRW5ITVJ?
GOTONX73UnMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDTTWM2OD1|Mz61NlU5KM7:TR?=MVnTRW5ITVJ?
YAPCM3;XV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MonLTWM2OD1|Mz64NVU6KM7:TR?=NELvO4ZUSU6JRWK=
LCLC-103HNHzYT|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVfJW|I1UUN3ME2zOE4yPjJ2IN88US=>MUHTRW5ITVJ?
SiHaMkDGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX3CcFViUUN3ME2zOE4{QDF5IN88US=>M2n6Z3NCVkeHUh?=
LK-2MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\XTWM2OD1|ND61O|A5KM7:TR?=MUPTRW5ITVJ?
KP-N-YSM3GyV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV70dIloUUN3ME2zOE44OjB{IN88US=>M1XWNnNCVkeHUh?=
NCI-SNU-1MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoPGTWM2OD1|NT6xO|kh|ryPMnnvV2FPT0WU
KNS-81-FDNFrzWplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLMSGt1UUN3ME2zOU43PjNizszNM1nN[3NCVkeHUh?=
SCC-9M2TnSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXfUOmQ3UUN3ME2zOk44OTR4IN88US=>MmjFV2FPT0WU
SH-4NYfpVVB5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVPJR|UxRTN4LkezJO69VQ>?M3zFOnNCVkeHUh?=
HCC-1954MonMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoGyTWM2OD1|Nz6yO|I6KM7:TR?=M3rQbHNCVkeHUh?=
BALL-1NHT4ZolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTN5LkWzNVYh|ryPMo[xV2FPT0WU
BE-13MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUTJR|UxRTN5LkewNVgh|ryPM4q3dXNCVkeHUh?=
COLO-678M{[yW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmjPTWM2OD1|Nz65OFM4KM7:TR?=NILxSIpUSU6JRWK=
SK-MEL-3M3y0ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\lWlVKSzVyPUO4MlI{QTdizszNMn7SV2FPT0WU
OAW-28NXPrdW5{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF7Uc2dKSzVyPUO4MlY{QSEQvF2=MWrTRW5ITVJ?
CAMA-1NYPiWo9rT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVPaRZMyUUN3ME2zPE46PjlzIN88US=>MYPTRW5ITVJ?
C2BBe1Mm[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILK[W1KSzVyPUO5MlgyQCEQvF2=MX\TRW5ITVJ?
A3-KAWMnnCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NITNd3JKSzVyPUSwMlM3PjFizszNNFe0XYdUSU6JRWK=
SK-MEL-24NH:2THlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTRyLkW5N|Eh|ryPMmXWV2FPT0WU
KYSE-140MmjxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnv5TWM2OD12MD63NVY2KM7:TR?=NXrrRW1JW0GQR1XS
MOLT-16NH\XTGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXr[49KSzVyPUSxMlE2OzZizszNNX72T4lUW0GQR1XS
CFPAC-1NHOxWlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zq[2lEPTB;NEKuOVIyOSEQvF2=Mm\jV2FPT0WU
NB14M3z0OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTDRWt3UUN3ME20Nk44ODJ5IN88US=>M2n3SHNCVkeHUh?=
COLO-792M2TtPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXSzfHB2UUN3ME20Nk45QTZzIN88US=>MmjhV2FPT0WU
RH-1NHn6cmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTR|LkS4N|Yh|ryPNXrXdXM3W0GQR1XS
NCI-H522MnH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MojkTWM2OD12ND6zOVY5KM7:TR?=NHjSSmtUSU6JRWK=
Ca-SkiNEDwUFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml7WTWM2OD12ND64NVE1KM7:TR?=NHvkNndUSU6JRWK=
KGNMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml3DTWM2OD12OD6zNFY{KM7:TR?=MV\TRW5ITVJ?
UACC-62NFXG[2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NInIR2dKSzVyPUS4MlQxPzJizszNMUnTRW5ITVJ?
NCI-H358M2myeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnXCTWM2OD12OT6zNFE5KM7:TR?=MXPTRW5ITVJ?
LS-411NMofiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;CbWlEPTB;NEmuN|EyQCEQvF2=M4rm[XNCVkeHUh?=
IST-MES1MoHmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3HsZWlEPTB;NEmuOVYzPSEQvF2=NHn3dGVUSU6JRWK=

... Click to View More Cell Line Experimental Data

In vivo Administration of GDC-0941 at 75 mg/kg/day displays significant inhibitory effect against established human U87MG glioblastoma xenografts in female NCr athymic mice, with tumor growth inhibition of 83%. [1] Oral administration of GDC-0941 at 150 mg/kg/day inhibits the growth of HER2-amplified, trastuzumab-resistant MDA-MB-361.1 xenografts in mice, and significantly delays the tumor progression, in association with potent induced apoptosis in tumors. [2] GDC-0941 (75 mg/kg/day) treatment for 2 weeks induces ~40% reduction in tumor volume of spontaneous B-cell follicular lymphomas developed in PTEN+/-LKB1+/hypo mice, accompanied by ablation of phosphorylation of Akt, S6K and SGK (serum and glucocorticoid protein kinase) protein kinases. [4]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Scintillation proximity assay Recombinant human PI3Kα, PI3Kβ, and PI3Kδ are coexpressed in a Sf9 baculovirus system with the p85α regulatory subunit and purified as GST-fusion proteins using affinity chromatography on glutathione-sepharose. Recombinant human PI3Kγ is expressed as monomeric GST-fusions and purified similarly. GDC-0941 is dissolved in DMSO and added to 20 mM Tris-HCl (pH 7.5) containing 200 μg yttrium silicate (Ysi) polylysine SPA beads, 4 mM MgCl2, 1 mM dithiothreitol (DTT), 1 μM ATP, 0.125 μCi [γ-33P]-ATP, and 4% (v/v) DMSO in a total volume of 50 μL. The recombinant GST-fusion of PI3Kα (5 ng), PI3Kβ (5 ng), PI3Kδ (5 ng), or PI3Kγ (5 ng) is added to the assay mixture to initiate the kinase reaction. After incubation for 1 hour at room temperature, the kinase reaction is terminated with 150 μL PBS. The mixture is then centrifuged for 2 minutes at 2000 rpm and read using a Wallac Microbeta counter. The reported IC50 values are calculated using a sigmoidal, dose-response curve fit in MDL Assay Explorer.

Cell Assay: [2]

Cell lines SKBR-3, BT474-M1, AU-565, HCC-1419, ZR75-30, KPL-4, JIMT-1, BT474-EEI, HCC-1954, MCF-7, CALU-3, SKOV-3, and MKN-7 cells
Concentrations Dissolved in DMSO, final concentrations ~10 μM
Incubation Time 48 and 72 hours
Method Cells are exposed to various concentrations of GDC-0941 for 48, and 72 hours. Proliferation/viability of cells is detected by using the CellTiter-Glo Luminescent Cell Viability Assay. The pAkt (Ser473), cleaved caspase-3, and cleaved PARP are analyzed by western blot. The Caspase-Glo 3/7 assay and the Cell Death Detection ELISAplus assay are used to detect caspase 3/7 activity, and apoptosis, respectively.

Animal Study: [2]

Animal Models NCR nude mice implanted with MDA-MB-361.1 cells, and SCID, C.B-17/IcrHsd-Prkdcscid mice implanted subcutaneously with BT474-M1 cells
Formulation Dissolved in 10% DMSO, 5% Tween 20, 85% water
Dosages ~150 mg/kg/day
Administration Oral gavage

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Folkes AJ, et al. J Med Chem, 2008, 51(18), 5522-5532.

[2] Junttila TT, et al. Cancer Cell, 2009, 15(5), 429-440.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02092831 Completed Healthy Volunteer Genentech, Inc. April 2014 Phase 1
NCT01740336 Active, not recruiting Breast Cancer Genentech, Inc. February 2013 Phase 2
NCT01493843 Completed Non-Squamous Non-Small Cell Lung Cancer Genentech, Inc. January 2012 Phase 2
NCT01437566 Completed Breast Cancer Genentech, Inc. October 2011 Phase 2
NCT01474668 Completed Healthy Volunteer Genentech, Inc. October 2011 Phase 1

view more

Chemical Information

Download Pictilisib (GDC-0941) SDF
Molecular Weight (MW) 513.64
Formula

C23H27N7O3S2

CAS No. 957054-30-7
Storage 3 years -20℃powder
2 years -80℃in solvent
Synonyms RG7321
Solubility (25°C) * In vitro DMSO 44 mg/mL (85.66 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 2% DMSO+30% PEG 300+5% Tween 80+ddH2O 5mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PI3K Products

  • GDC-0032

    GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

    Features:A beta isoform-sparing PI3K inhibitor.

  • Pilaralisib (XL147)

    Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ. Phase 1/2.

  • GNE-317

    GNE-317 is a potent, brain-penetrant PI3K inhibitor.

  • LY294002

    LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation.

  • 3-Methyladenine (3-MA)

    3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.

  • CAL-101 (Idelalisib, GS-1101)

    CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM in cell-free assays; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.

  • Wortmannin

    Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

  • BEZ235 (NVP-BEZ235, Dactolisib)

    BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.

  • BKM120 (NVP-BKM120, Buparlisib)

    BKM120 (NVP-BKM120, Buparlisib) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2.

  • Alpelisib (BYL719)

    Alpelisib (BYL719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.

Recently Viewed Items

Tags: buy Pictilisib (GDC-0941) | Pictilisib (GDC-0941) supplier | purchase Pictilisib (GDC-0941) | Pictilisib (GDC-0941) cost | Pictilisib (GDC-0941) manufacturer | order Pictilisib (GDC-0941) | Pictilisib (GDC-0941) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us